Similar articles

• Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

  Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG. Athyros VG, et al. Curr Med Res Opin. 2002;18(4):220-8. doi: 10.1185/030079902125000787. Curr Med Res Opin. 2002. PMID: 12201623 Clinical Trial.
• [Disturbances in cholesterol metabolism].

  Marschall HU. Marschall HU. Dtsch Med Wochenschr. 2001 Jan 19;126(3):63-4. doi: 10.1055/s-2001-10347. Dtsch Med Wochenschr. 2001. PMID: 11205483 German. No abstract available.
• Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.

  Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Mercouris BR, Pehlivanidis A, Bouloukos VI, Elisaf M; GREACE Collaborative Group. Athyros VG, et al. Curr Med Res Opin. 2004 May;20(5):627-37. doi: 10.1185/030079904125003421. Curr Med Res Opin. 2004. PMID: 15171226 Clinical Trial.
• [Atorvastatin].

  Kajinami K, Takekoshi N. Kajinami K, et al. Nihon Rinsho. 2001 Mar;59 Suppl 3:598-604. Nihon Rinsho. 2001. PMID: 11347138 Review. Japanese. No abstract available.
• ["Treating to New Targets": plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease].

  Scheen AJ. Scheen AJ. Rev Med Liege. 2005 Apr;60(4):264-7. Rev Med Liege. 2005. PMID: 15943105 Review. French.